ANTIPODES PARTNERS Ltd Has $77.02 Million Position in Ventas, Inc. $VTR

ANTIPODES PARTNERS Ltd cut its stake in shares of Ventas, Inc. (NYSE:VTR) by 28.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,100,395 shares of the real estate investment trust’s stock after selling 435,646 shares during the quarter. Ventas makes up about 1.7% of ANTIPODES PARTNERS Ltd’s portfolio, making the stock its 26th largest position. ANTIPODES PARTNERS Ltd’s holdings in Ventas were worth $77,022,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Norges Bank acquired a new position in shares of Ventas during the second quarter valued at about $344,740,000. Vanguard Group Inc. increased its stake in Ventas by 4.1% during the 2nd quarter. Vanguard Group Inc. now owns 71,796,312 shares of the real estate investment trust’s stock valued at $4,533,937,000 after purchasing an additional 2,854,751 shares in the last quarter. Citigroup Inc. increased its stake in Ventas by 451.9% during the 2nd quarter. Citigroup Inc. now owns 2,316,344 shares of the real estate investment trust’s stock valued at $146,277,000 after purchasing an additional 1,896,627 shares in the last quarter. State Street Corp raised its holdings in Ventas by 5.2% during the second quarter. State Street Corp now owns 27,998,629 shares of the real estate investment trust’s stock worth $1,781,267,000 after buying an additional 1,388,678 shares during the last quarter. Finally, Invesco Ltd. lifted its stake in shares of Ventas by 36.1% in the second quarter. Invesco Ltd. now owns 4,812,970 shares of the real estate investment trust’s stock valued at $303,939,000 after buying an additional 1,275,446 shares in the last quarter. 94.18% of the stock is owned by institutional investors.

Ventas Stock Up 0.5%

VTR opened at $85.87 on Friday. The firm has a market capitalization of $40.78 billion, a P/E ratio of 159.01, a price-to-earnings-growth ratio of 2.09 and a beta of 0.77. The company has a debt-to-equity ratio of 1.03, a current ratio of 0.67 and a quick ratio of 0.67. The company has a fifty day moving average price of $79.25 and a 200-day moving average price of $74.46. Ventas, Inc. has a one year low of $60.15 and a one year high of $87.24.

Ventas (NYSE:VTR) last issued its quarterly earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 EPS for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). Ventas had a return on equity of 2.09% and a net margin of 4.31%.The company had revenue of ($1,229.71) million during the quarter, compared to the consensus estimate of $1.53 billion. During the same period in the previous year, the company earned $0.81 EPS. Ventas’s quarterly revenue was up 21.7% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Equities research analysts expect that Ventas, Inc. will post 3.4 earnings per share for the current fiscal year.

Ventas Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, April 16th. Shareholders of record on Tuesday, March 31st will be given a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend is Tuesday, March 31st. This is an increase from Ventas’s previous quarterly dividend of $0.48. Ventas’s dividend payout ratio is currently 355.56%.

Insider Buying and Selling

In related news, CEO Debra A. Cafaro sold 10,322 shares of the firm’s stock in a transaction on Monday, February 2nd. The stock was sold at an average price of $77.66, for a total value of $801,606.52. Following the completion of the sale, the chief executive officer owned 1,114,034 shares of the company’s stock, valued at $86,515,880.44. This trade represents a 0.92% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Carey S. Roberts sold 35,532 shares of the company’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total value of $3,020,220.00. Following the completion of the sale, the executive vice president directly owned 72,755 shares in the company, valued at approximately $6,184,175. The trade was a 32.81% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 86,106 shares of company stock valued at $6,931,397 over the last ninety days. 0.80% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on VTR shares. Jefferies Financial Group reissued a “buy” rating and set a $93.00 target price on shares of Ventas in a research report on Monday, December 15th. Argus set a $88.00 price target on Ventas in a research note on Tuesday, February 10th. Royal Bank Of Canada increased their price target on Ventas from $83.00 to $91.00 and gave the company an “outperform” rating in a research report on Tuesday, February 10th. KeyCorp increased their target price on shares of Ventas from $85.00 to $90.00 and gave the company an “overweight” rating in a report on Tuesday, February 10th. Finally, Morgan Stanley set a $90.00 price target on shares of Ventas in a research report on Friday, February 13th. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $86.87.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.